vs

Side-by-side financial comparison of GENESIS ENERGY LP (GEL) and NATIONAL HEALTHCARE CORP (NHC). Click either name above to swap in a different company.

GENESIS ENERGY LP is the larger business by last-quarter revenue ($440.8M vs $386.5M, roughly 1.1× NATIONAL HEALTHCARE CORP). NATIONAL HEALTHCARE CORP runs the higher net margin — 6.4% vs 4.5%, a 1.9% gap on every dollar of revenue. On growth, GENESIS ENERGY LP posted the faster year-over-year revenue change (10.5% vs 4.6%). GENESIS ENERGY LP produced more free cash flow last quarter ($87.0M vs $6.4M). Over the past eight quarters, NATIONAL HEALTHCARE CORP's revenue compounded faster (14.0% CAGR vs 0.7%).

Genesis Energy LP is a U.S.-based midstream energy limited partnership that operates critical infrastructure for crude oil, natural gas, refined petroleum products, and specialty industrial materials. Its core assets include pipelines, storage terminals, marine facilities, and rail logistics hubs, serving refineries, industrial clients, and energy distributors across North America.

HCA Healthcare, Inc. is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by to...

GEL vs NHC — Head-to-Head

Bigger by revenue
GEL
GEL
1.1× larger
GEL
$440.8M
$386.5M
NHC
Growing faster (revenue YoY)
GEL
GEL
+5.8% gap
GEL
10.5%
4.6%
NHC
Higher net margin
NHC
NHC
1.9% more per $
NHC
6.4%
4.5%
GEL
More free cash flow
GEL
GEL
$80.6M more FCF
GEL
$87.0M
$6.4M
NHC
Faster 2-yr revenue CAGR
NHC
NHC
Annualised
NHC
14.0%
0.7%
GEL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GEL
GEL
NHC
NHC
Revenue
$440.8M
$386.5M
Net Profit
$19.9M
$24.8M
Gross Margin
Operating Margin
20.4%
8.6%
Net Margin
4.5%
6.4%
Revenue YoY
10.5%
4.6%
Net Profit YoY
140.2%
308.6%
EPS (diluted)
$0.04
$1.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GEL
GEL
NHC
NHC
Q4 25
$440.8M
$386.5M
Q3 25
$414.0M
$382.7M
Q2 25
$377.3M
$374.9M
Q1 25
$398.3M
$373.7M
Q4 24
$398.9M
$369.4M
Q3 24
$397.3M
$340.2M
Q2 24
$430.2M
$300.7M
Q1 24
$434.4M
$297.2M
Net Profit
GEL
GEL
NHC
NHC
Q4 25
$19.9M
$24.8M
Q3 25
$9.2M
$39.2M
Q2 25
$-406.0K
$23.7M
Q1 25
$-469.1M
$32.2M
Q4 24
$-49.4M
$6.1M
Q3 24
$-17.2M
$42.8M
Q2 24
$-8.7M
$26.8M
Q1 24
$11.4M
$26.2M
Operating Margin
GEL
GEL
NHC
NHC
Q4 25
20.4%
8.6%
Q3 25
19.0%
7.9%
Q2 25
17.9%
9.1%
Q1 25
5.5%
8.2%
Q4 24
3.4%
7.8%
Q3 24
12.2%
6.7%
Q2 24
11.6%
7.5%
Q1 24
13.4%
5.3%
Net Margin
GEL
GEL
NHC
NHC
Q4 25
4.5%
6.4%
Q3 25
2.2%
10.3%
Q2 25
-0.1%
6.3%
Q1 25
-117.8%
8.6%
Q4 24
-12.4%
1.6%
Q3 24
-4.3%
12.6%
Q2 24
-2.0%
8.9%
Q1 24
2.6%
8.8%
EPS (diluted)
GEL
GEL
NHC
NHC
Q4 25
$0.04
$1.58
Q3 25
$-0.05
$2.50
Q2 25
$-0.12
$1.52
Q1 25
$-4.06
$2.07
Q4 24
$-0.58
$0.38
Q3 24
$-0.32
$2.73
Q2 24
$-0.25
$1.73
Q1 24
$-0.09
$1.69

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GEL
GEL
NHC
NHC
Cash + ST InvestmentsLiquidity on hand
$6.4M
$92.8M
Total DebtLower is stronger
$3.0B
$40.0M
Stockholders' EquityBook value
$1.1B
Total Assets
$4.9B
$1.5B
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GEL
GEL
NHC
NHC
Q4 25
$6.4M
$92.8M
Q3 25
$4.9M
$130.6M
Q2 25
$4.5M
$111.0M
Q1 25
$377.4M
$90.4M
Q4 24
$7.4M
$76.1M
Q3 24
$13.0M
$84.8M
Q2 24
$13.7M
$136.2M
Q1 24
$7.0M
$94.0M
Total Debt
GEL
GEL
NHC
NHC
Q4 25
$3.0B
$40.0M
Q3 25
$3.1B
$73.1M
Q2 25
$3.1B
$110.0M
Q1 25
$3.4B
$134.0M
Q4 24
$3.7B
$137.0M
Q3 24
$4.0B
$147.0M
Q2 24
$3.9B
Q1 24
$3.8B
Stockholders' Equity
GEL
GEL
NHC
NHC
Q4 25
$1.1B
Q3 25
$1.1B
Q2 25
$1.0B
Q1 25
$1.0B
Q4 24
$980.2M
Q3 24
$983.5M
Q2 24
$945.8M
Q1 24
$924.7M
Total Assets
GEL
GEL
NHC
NHC
Q4 25
$4.9B
$1.5B
Q3 25
$4.9B
$1.6B
Q2 25
$4.8B
$1.6B
Q1 25
$5.2B
$1.5B
Q4 24
$7.0B
$1.5B
Q3 24
$7.1B
$1.6B
Q2 24
$7.0B
$1.3B
Q1 24
$6.9B
$1.3B
Debt / Equity
GEL
GEL
NHC
NHC
Q4 25
0.04×
Q3 25
0.07×
Q2 25
0.11×
Q1 25
0.13×
Q4 24
0.14×
Q3 24
0.15×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GEL
GEL
NHC
NHC
Operating Cash FlowLast quarter
$110.8M
$16.8M
Free Cash FlowOCF − Capex
$87.0M
$6.4M
FCF MarginFCF / Revenue
19.7%
1.7%
Capex IntensityCapex / Revenue
5.4%
2.7%
Cash ConversionOCF / Net Profit
5.58×
0.68×
TTM Free Cash FlowTrailing 4 quarters
$65.9M
$148.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GEL
GEL
NHC
NHC
Q4 25
$110.8M
$16.8M
Q3 25
$70.3M
$66.2M
Q2 25
$47.0M
$62.8M
Q1 25
$24.8M
$39.3M
Q4 24
$74.0M
$12.8M
Q3 24
$87.3M
$34.2M
Q2 24
$104.7M
$50.7M
Q1 24
$125.9M
$9.6M
Free Cash Flow
GEL
GEL
NHC
NHC
Q4 25
$87.0M
$6.4M
Q3 25
$43.3M
$56.5M
Q2 25
$-7.6M
$52.6M
Q1 25
$-56.8M
$33.1M
Q4 24
$-47.1M
$4.6M
Q3 24
$-32.3M
$28.6M
Q2 24
$-67.5M
$42.8M
Q1 24
$-48.3M
$3.7M
FCF Margin
GEL
GEL
NHC
NHC
Q4 25
19.7%
1.7%
Q3 25
10.5%
14.8%
Q2 25
-2.0%
14.0%
Q1 25
-14.3%
8.9%
Q4 24
-11.8%
1.3%
Q3 24
-8.1%
8.4%
Q2 24
-15.7%
14.2%
Q1 24
-11.1%
1.2%
Capex Intensity
GEL
GEL
NHC
NHC
Q4 25
5.4%
2.7%
Q3 25
6.5%
2.5%
Q2 25
14.5%
2.7%
Q1 25
20.5%
1.6%
Q4 24
30.3%
2.2%
Q3 24
30.1%
1.7%
Q2 24
40.0%
2.6%
Q1 24
40.1%
2.0%
Cash Conversion
GEL
GEL
NHC
NHC
Q4 25
5.58×
0.68×
Q3 25
7.63×
1.69×
Q2 25
2.65×
Q1 25
1.22×
Q4 24
2.10×
Q3 24
0.80×
Q2 24
1.89×
Q1 24
11.09×
0.37×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GEL
GEL

Onshore Facilities And Transportation Revenue$204.2M46%
Offshore Pipeline Transportation Revenue$154.3M35%
Marine Transportation Revenue$82.2M19%

NHC
NHC

Inpatient Services Segment$333.7M86%
Homecare Services Segment$40.0M10%
Other$11.2M3%
National$1.6M0%

Related Comparisons